The α-Helical Antibacterial Peptides Derived from Mastoparan with Broad-Spectrum Activity against Multidrug-Resistant...

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Antibiotic resistance is a growing global health threat.
• Antimicrobial peptides (AMPs) are emerging as a potential alternative to conventional antibiotics.
• The need for novel therapeutic agents against multidrug-resistant (MDR) bacteria is critical.

Purpose of the Study:

• To design and synthesize novel antimicrobial peptides derived from MP9.
• To evaluate the efficacy and safety of these novel peptides against multidrug-resistant bacteria.
• To elucidate the mechanism of action of the most promising peptide candidate.

Main Methods:

• Peptide design through amino acid substitution (tryptophan for alanine) and rearrangement.
• Synthesis and characterization of novel peptide derivatives.
• In vitro assessment of antibacterial activity, cytotoxicity, and hemolysis.
• In vivo efficacy studies in a mouse infection model.

Main Results:

• MP9-10 exhibited superior activity against multidrug-resistant bacteria compared to other derivatives.
• MP9-10 demonstrated the lowest cytotoxicity and hemolysis, indicating a favorable safety profile.
• Membrane disruption was identified as the primary mechanism of bacterial killing by MP9-10.
• MP9-10 effectively treated Staphylococcus aureus infections in a mouse model.

Conclusions:

• MP9-10 is a potent antimicrobial peptide with broad-spectrum activity against multidrug-resistant bacteria.
• MP9-10 possesses a favorable safety profile, with low cytotoxicity and hemolysis.
• The membrane disruption mechanism contributes to MP9-10's efficacy.
• MP9-10 represents a promising therapeutic candidate for treating multidrug-resistant bacterial infections.